It is recommended that patients be treated with IntronA alone for at least 3 to 4 months, at which point HCV-RNA status should be determined.
IntronA monoteraapiat soovitatakse patsientidel rakendada vähemalt 3... 4 kuu jooksul, mille järel määratakse HCV- RNA staatus.